News

      Funding Opportunities

      Job Openings

      Mission of SMI

      Corporate Supporters

      Links of Interest

      Contact SMI Office

      Member Only Site

      Troubleshoot Journal Access

 
Mission

An international scientific educational organization whose purpose is to advance our understanding of biology and medicine through noninvasive in vivo investigation of cellular molecular events involved in normal and pathologic processes.

History | Council | Founding Members
Constitution | By Laws

SMI Achievement Award

Once a year, Society members are asked to vote for an Achievment Award recipient from a list of candidates that have been nominated by the Council and Nominating Committee. This award is given to an individual who has made a fundamental discovery in the field of Molecular Imaging that has changed the direction of the field, or enabled new in vivo investigations that were not possible prior to their contribution.

Recipients include:

  • 2002 - Juri Gelovani, MD, PhD, UT MD Anderson Cancer Center, Houston, TX USA
  • 2003 - Ralph Weissleder, MD, PhD, Massachusetts General Hospital, Harvard, Charlestown, MA USA
  • 2004 - Sanjiv "Sam" Gambhir, MD, PhD, Stanford University, Stanford, CA USA
  • 2005 - David Piwnica-Worms, MD, PhD, Washington University Medical School, St. Louis, MO USA
  • 2006 - Christopher H. Contag, PhD, Stanford University School of Medicine, Stanford, CA USA

And proudly announcing this year's recipient to receive the Molecular Imaging Achievement Award:

Michael J. Welch, PhD
Professor of Radiology and Chemistry
Professor of Molecular Biology and Pharmacology
Professor of Biomedical Engineering Program
Head of Oncologic Imaging Research Program, Siteman Cancer Center
Mallinckrodt Institute of Radiology
Washington University
St. Louis, Missouri USA

Dr. Welch was nominated for over 40 years of innovations in putting radionuclides on molecules that target metabolic and physiologic processes in the body as well as for developing new methods of generating radionuclides using reactors and accelerators.